COMMON MAPS
Map version new-york activity top-down
Main site Contact
Menu
↑ parent activity group ·
research dossier

NEW YORK CROHNS AND COLITIS ORGANIZATION INC
SYOSSET, NY · EIN 812810513 · Form 990 · FY2024 · NTEE G70 · Voluntary Health Associations · Micro (<$100K)
revenue
$1K
expenses
$4K
net assets
$77K
employees
0
program ratio
0%
mission · from form 990

NYCCO IS ORGANIZED TO CONDUCT, HAVE PUBLISHED, AND DISTRIBUTE RESEARCH, STUDIES, AND ANALYSIS RELATING TO IBD. TO THAT END, NYCCO SEEKS TO ENHANCE THE LEVEL OF CARE FOR PATIENTS IN THE NEW YORK METROPOLITAN AREA SUFFERING FROM IBD, THROUGH COLLABORATIVE AND TRANSLATIONAL RESEARCH AND IMPROVED COOPERATION AMONGST IBD CLINICIANS IN THE NEW YORK AREA. NYCCO CAN BETTER ACHIEVE THIS GOAL BY GENERATING PUBLIC INTEREST IN IMPROVING TREATMENTS OR FINDING A CURE FOR THE DISEASE.

profile · synthesized from sources

Nonprofit organization focused on improving care for patients with inflammatory bowel disease (IBD) in the New York metropolitan area. Conducts and disseminates research, promotes collaboration among clinicians, and raises public awareness about IBD. Organized to support translational research and enhance treatment options toward finding a cure.

named programs · 3 · from sources

What they call their work

Clinician Collaboration Network
Fosters cooperation among IBD specialists in the New York area to advance translational research and share best practices
IBD Research and Analysis
Conducts, publishes, and distributes research and studies related to inflammatory bowel disease to improve clinical care and patient outcomes
Public Awareness Campaign
Generates public interest in IBD to promote understanding, support, and funding for improved treatments and a potential cure
activities · 1 group

What they do

  • Inflammatory Bowel Disease Research and Support 1 activity
    • Conduct and distribute research on inflammatory bowel disease
      Conducts, publishes, and distributes research, studies, and analysis related to inflammatory bowel disease (IBD) to enhance patient care in the New York metropolitan area.
financials · form 990 · fy2024
revenue
Total revenue$1K
Contributions & grants$1K97%
Program service revenue$00%
Investment income$403%
Other revenue$0
expenses
Total expenses$4K
Program expenses0%
Admin / overhead100%
Fundraising0%
Salaries & benefits$0
Grants paid out$0
Largest expense lineOther
balance sheet
Total assets$77K
Cash$77K
Investments$0
Liabilities$0
Net assets$77K
Liquid reserves214.3 mo
5 years on record · 2020–2024 · YoY revenue -98.4%
leadership · form 990 part vii · fy2024

Who runs it

board members · 4
  • JORDAN AXELRAD MD — TREASURER
  • KEITH SULTAN MD — PRESIDENT
  • MANASI AGRAWAL MD — SECRETARY
  • ROBERT HIRTEN MD — VICE PRESIDE
strategies · 1

How they approach the work

Named approaches extracted from this org’s sources. Where others share an approach, follow it to see the full set of orgs running it.

  • Collaborative Translational Research
    methodology: collaborative_translational_research
    By integrating research with clinical practice and fostering collaboration among IBD clinicians, we improve patient care, because translating scientific findings into clinical settings enhances treatment effectiveness and patient outcomes.